Medicare Part D coverage · dicyclomine hydrochloride · RxCUI 991061
dicyclomine hydrochloride 10 MG Oral Capsule
Per the CMS 2026 Part D formulary file, dicyclomine hydrochloride 10 MG Oral Capsule is covered by 5,052 Medicare Part D plans (100% of enrollable products), averaging Tier 2, with prior authorization required on 41.5% of covering formularies.
- 100%
- Plan coverage
- 5,052
- Plans covering
- T2
- Avg tier
- 41.5%
- Prior auth required
What the CMS Formulary Data Shows for dicyclomine hydrochloride 10 MG Oral Capsule
Per the CMS 2026 Part D formulary file, dicyclomine hydrochloride 10 MG Oral Capsule (RxNorm concept RXCUI 991061, generic name dicyclomine hydrochloride) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.
Real-world access to dicyclomine hydrochloride 10 MG Oral Capsule depends on utilization management as much as tier placement: 41.5% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 887,927 Part D beneficiaries filled dicyclomine hydrochloride 10 MG Oral Capsule in 2023, with total plan-and-beneficiary spending of $53,307,717 and an average per-beneficiary annual cost of $60.04. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry dicyclomine hydrochloride 10 MG Oral Capsule today.
Coverage Details
- Formularies covering
- 328
- Plans covering
- 5,052
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 41.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 887,927
- Total spending
- $53,307,717
- Avg per beneficiary
- $60.04
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering dicyclomine hydrochloride 10 MG Oral Capsule
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | Yes | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | Yes | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | Yes | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T1 | Yes | $0 | CA |
| Anthem Full Dual Advantage (HMO D-SNP) | Anthem Insurance Companies, Inc. | T1 | Yes | $0 | IN |
| Anthem I PathWays Dual Care Advantage (HMO D-SNP) | Anthem Insurance Companies, Inc. | T1 | Yes | $0 | IN |
| Anthem I PathWays Dual Care Advantage NFLOC (HMO D-SNP) | Anthem Insurance Companies, Inc. | T1 | Yes | $0 | IN |
| Wellpoint Full Dual Advantage (HMO-POS D-SNP) | Wellpoint Iowa, Inc. | T1 | Yes | $0 | IA |
| Wellpoint Full Dual Advantage 2 (HMO-POS D-SNP) | Wellpoint Iowa, Inc. | T1 | Yes | $0 | IA |
| Wellpoint Full Dual Advantage (HMO D-SNP) | Wellpoint West Virginia , Inc. | T1 | Yes | $0 | WV |
| Wellpoint Full Dual Advantage (HMO D-SNP) | Wellpoint Washington, Inc. | T1 | Yes | $0 | WA |
| Wellpoint Dual Advantage (HMO D-SNP) | Wellpoint Washington, Inc. | T1 | Yes | $0 | WA |
| Healthy Blue Dual Advantage (HMO D-SNP) | Community Care Health Plan OF Louisiana, Inc. | T1 | Yes | $0 | LA |
| Healthy Blue Dual Advantage 2 (HMO D-SNP) | Community Care Health Plan OF Louisiana, Inc. | T1 | Yes | $0 | LA |
| Anthem Dual Advantage (PPO D-SNP) | Anthem Insurance Companies, Inc. | T1 | Yes | $0 | VA |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Texas, Inc. | T1 | Yes | $0 | TX |
| Wellpoint Kidney Care (HMO-POS C-SNP) | Wellpoint Texas, Inc. | T1 | Yes | $0 | TX |
| Wellpoint Dual Advantage 2 (HMO D-SNP) | Wellpoint Texas, Inc. | T1 | Yes | $0 | TX |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is dicyclomine hydrochloride 10 MG Oral Capsule covered by Medicare Part D?
Yes, dicyclomine hydrochloride 10 MG Oral Capsule is covered by 5,052 Medicare Part D plans (100% of all Part D formularies).
What tier is dicyclomine hydrochloride 10 MG Oral Capsule on Medicare Part D plans?
dicyclomine hydrochloride 10 MG Oral Capsule averages Tier 2 across Part D plans, ranging from Tier 1 to Tier 4.
Does dicyclomine hydrochloride 10 MG Oral Capsule require prior authorization?
41.5% of Part D formularies require prior authorization for dicyclomine hydrochloride 10 MG Oral Capsule. Step therapy: 0%. Quantity limits: 0.6%.
How much does Medicare spend on dicyclomine hydrochloride 10 MG Oral Capsule?
In 2023, total Medicare Part D spending on dicyclomine hydrochloride 10 MG Oral Capsule was $53,307,717, covering 887,927 beneficiaries. The average spend per beneficiary was $60.04.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- acetaminophen 300 MG / codeine phosphate 60 MG Oral Tablet T2
- azelastine hydrochloride 0.5 MG/ML Ophthalmic Solution T2
- doxycycline hyclate 20 MG Oral Tablet T2
- amantadine hydrochloride 10 MG/ML Oral Solution T2
- {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Lyza] T2
- {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Incassia 28 Day] T2
Similar prior-authorization rate
- isotretinoin 40 MG Oral Capsule 41.5% PA
- methylprednisolone 32 MG Oral Tablet 41.5% PA
- methylprednisolone 16 MG Oral Tablet 41.5% PA
- methylprednisolone 8 MG Oral Tablet 41.5% PA
- topiramate 25 MG/ML Oral Solution [Eprontia] 41.4% PA
- isotretinoin 20 MG Oral Capsule [Claravis] 41.6% PA